Presentation Information
[LS-26-1]The development of high-dose methylcobalamin (Rozebalamin), a new treatment for ALS ~Early diagnosis becomes even more important~
Yuishin Izumi (Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Professor, Japan)